We compared results of measurement of prostatic acid phosphatase activity in serum and various tissues by enzymatic assay and radioimmunoassay. By enzymatic assay, activity in serum is lost rapidly, even at room temperature. In contrast, there was no change in antigenic activity during 48 h by radioimmunoassay.
Measurement of its activity in the serum became clinically important after it was discovered that prostatic acid phosphatase activity usually increases as a consequence of prostatic carcinoma (1) (2) (3) (4) (5) and that the activity in the serum generally increases as the disease progresses (6). Many substrates have been used in measuring this activity in patients' serum (7-13). Polypropylene tubes were coated with 0.5 ml of rabbit antiserum, diluted 3000-fold, for 1 h at 4#{176}C. After the antiserum was aspirated, the walls of the tubes were washed twice with 1 ml of PBS, and they were allowed to stand for 45 mm at room temperature with PBS containing 10 g of BSA per liter.4 The contents of the tubes were aspirated and 0.4 ml of saline, 0.1 ml of sample, and 10 il of 1251-labeled antigen (2 X 10 cpm) were added. The tubes were left at 4 #{176}C for 36 h and, after the removal of the free antigen, the walls of the tubes were washed twice with PBS and counted in a gamma counter. This assay has been described in detail previously (15).
Materials and Methods

Stability of serum prostatic acid phosphatase:
Blood was obtained from prostatic cancer patients by venipuncture.
The serum (pH 8.4) was separated by centrifugation, divided into three portions, and incubated at either 23, 36, or 46 #{176}C. Samples for the assay were taken at the indicated times and quickly frozen until they were measured by enzyme assay (p-nitrophenylphosphate substrate) and by radioimmunoassay.
To test the enzyme's stability to freezing and thawing, serum was frozen (solid C02/ethanol) and thawed 14 times and the activity then determined by enzymatic assay and radioimmunoassay.
Results
Stability:
The activity of serum prostatic acid phosphatase decreases rapidly at room temperature, owing to the increased pH of the serum (7). However, repeated freezing and thawing does not decrease either the enzyme activity or the immunological activity of prostatic acid phosphatase in the serum of prostatic cancer patients.
The serum retained all its original prostatic acid phosphatase activity after it had been frozen and thawed 14 times. Consequently, it is valid to store a series of samples frozen and later measure their activity at one time. . .
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2 of prostatic and total acid phosphatase. Total acid phosphatase activity in the different extracts is in each case quite low, but the ratio of prostatic to total acid phosphatase in serum samples varies from 10 to 25%. Thus, it is essential to be sure one is measuring only prostatic acid phosphatase when assaying for this activity in serum. When cancer patients with other than prostatic cancer (37 men, 53 women) were evaluated for serum prostatic acid phosphtase, 26.6% (24/90) had "abovenormal" prostatic acid phosphatase values by enzymatic assay and 5.5% (5/90) had "above-normal" values by radioimmunoassay. Table 2 shows the distributions of tumors with "above-normal"serum prostatic acid phosphatase by radioimmunoassay and by enzyme assay. None of the women had "above-normal" prostatic acid phosphatase activity by radioimmunoassay. Three men had "above-normal" values by both methods: one with pharyngeal carcinoma had an extremely high value; one with epidermoid carcinoma of the lung, which metastasized to the parietal area of the brain, had moderately increased values; one with adenocarcinoma of the lung had a smaller increase. For the radioimmunoassay, 13.5% (5/37) of the male nonprostatic cancer patients had falsely positive assays for prostatic acid phosphatase by radioimmunoassay, a number that concurs with a preliminary study that showed 8 to 11%
false-positive tests for normal males (22) .
Discussion
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